Eye care specialist Optegra staged a dramatic turnaround in 2021 following its decision to rationalise the number of pathways offered and grow its NHS proposition. The company’s UK business reported EBITDA of £5.7m for the 18 months ended 31 December 2021 against a loss of almost £5m in the year to 30 June 2020. It said the…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
